Topotecan Plus Paclitaxel and Carboplatin in the Initial Treatment of Advanced Ovarian and Primary Peritoneal Carcinoma
type: MedicalStudy
description: A Phase II Study of a Three-Day Schedule of Topotecan Plus Paclitaxel and Carboplatin on Day Three in the Initial Treatment of Advanced Ovarian and Primary Peritoneal Carcinoma
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE2
start date: 2002-02
end date: 2006-06
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00193297
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: SCRI Development Innovations, LLC
study subject: Ovary Cancer
keywords: PHASE2
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Ovary Cancer

AI Analytics
type: Organization